Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000152

CFO and Secretary sold 119,524 shares at an average $44.88 ($5,363,716)

  • CFO and Secretary acquired 105,653 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise +20,547 $10.20 $209,579 53,814 D
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise +34,414 $16.00 $550,624 88,228 D
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise +44,079 $14.25 $628,126 132,307 D
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise +6,613 $15.44 $102,105 138,920 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −1,015 $42.00 $42,630 137,905 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −11,295 $41.87 $472,932 126,610 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −1,561 $42.68 $66,623 125,049 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −12,952 $41.65 $539,479 112,097 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −8,485 $42.34 $359,258 103,612 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −4,142 $43.50 $180,183 99,470 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −8,456 $45.18 $382,046 91,014 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −38,900 $45.93 $1,786,588 52,114 D
Levy Adam Scott CFO and Secretary 2025-11-11 Sale −32,718 $46.88 $1,533,977 19,396 D
Derivatives
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise · Stock Option −20,547 135,674 D
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise · Stock Option −34,414 20,662 D
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise · Stock Option −44,079 91,592 D
Levy Adam Scott CFO and Secretary 2025-11-11 Option exercise · Stock Option −6,613 4,888 D
Open-market sales · 119,524 sh · avg $44.88 · $5,363,716
Loading xslF345X05/wk-form4_1763078493.xml…